Exodus Point Capital Management, LP Savara Inc Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Savara Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 1,085,666 shares of SVRA stock, worth $4.67 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,085,666Holding current value
$4.67 Million% of portfolio
0.04%Shares
7 transactions
Others Institutions Holding SVRA
# of Institutions
122Shares Held
121MCall Options Held
123KPut Options Held
14.7K-
Nea Management Company, LLC Timonium, MD24.5MShares$105 Million8.55% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$62.6 Million10.96% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10MShares$43 Million5.24% of portfolio
-
Jennison Associates LLC8.84MShares$38 Million0.03% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.29MShares$35.6 Million0.08% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $490M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.